ALKERAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United States, South Africa

Active ingredients

The drug ALKERAN contains one active pharmaceutical ingredient (API):

1 Melphalan
UNII Q41OR9510P - MELPHALAN

Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication.

Read about Melphalan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ALKERAN Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01AA03 Melphalan L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 2547C
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 505617060041517, 505617060041617
Country: CA Health Products and Food Branch Identifier(s): 00004715, 02087286
Country: EE Ravimiamet Identifier(s): 1004410, 1006434, 1708770
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 125125
Country: FR Base de données publique des médicaments Identifier(s): 68262525, 68708664
Country: HK Department of Health Drug Office Identifier(s): 03792, 37994
Country: IE Health Products Regulatory Authority Identifier(s): 11193
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 1069
Country: JP 医薬品医療機器総合機構 Identifier(s): 4219002F1034, 4219403F1023
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1000049, 1006932
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 62511
Country: NL Z-Index G-Standaard Identifier(s): 13669249
Country: NL Z-Index G-Standaard, PRK Identifier(s): 35254, 65641
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10081, 309
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100003930, 100344736
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W58865001, W58865002
Country: SG Health Sciences Authority Identifier(s): 11822P, 11873P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699874080021
Country: US FDA, National Drug Code Identifier(s): 52609-0001
Country: ZA Health Products Regulatory Authority Identifier(s): 27/26/0506, 27/34/0507, H/26/2744

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.